Dexamethasone, a success for 3rd World countries on COVID-19 cure


THE Chief Executive Officer, Hi-TECH Diagnostics Ltd., Chief Samuel Ohiri has said that the discovery of dexamethasone as a cure for COVID-19 is a major breakthrough for Third World countries ravaged by poverty. 

Ohiri, a medical laboratory expert, said that the steroid was affordable at five pounds, about N15,000, described as a feat, the discovery of dexamethasone by World Health Organisation (WHO) as steroid for COVID-19. 

In an interview with the News Agency of Nigeria (NAN) on Thursday in Abuja, Ohiri said:

“Third World countries with little or no resources can comfortably afford the drugs.

“Dexamethasone has been very effective in the treatment of skin inflammation and severe acute respiratory syndromes right from 1960s.”

Chief Executive Officer, Hi-TECH Diagnostics Ltd., Chief Samuel Ohiri

He explained that the steroid had the potency of reducing COVID-19 mortalities from 50 per cent to 15 per cent.

“About 50 per cent of patients with severe acute respiratory syndrome who are placed on ventilators do not survive, but this steroid will reduce deaths by one-third,” he said.

He expressed delight over the discovery, described it as respite for patients in severe conditions and the world at large.

Ohiri, who is also the Chairman, Imo Council of Traditional Rulers, said that consistent education and awareness on the dangers of COVID-19 were needed out for the safety of communities.

The traditional ruler decried the level of ignorance about the reality of the COVID-19 pandemic and called on traditional institutions as well as religious institutions to take the lead in mass sensitisation.

He warned: “COVID-19 is real and very deadly, so let everyone continue to stay safe by washing hands, observing social distancing and take dexamethasone if infected.”


Please enter your comment!
Please enter your name here